Literature DB >> 11717083

Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies.

K P Mason1, E J Neufeld, V E Karian, D Zurakowski, B V Koka, P E Burrows.   

Abstract

OBJECTIVE: The purpose of our study was to examine the coagulation status in patients with vascular anomalies who had undergone sclerotherapy or embolization. SUBJECTS AND METHODS: Ours was a prospective pilot study of 29 patients who had undergone sclerotherapy or embolization of large vascular anomalies. Fibrinogen, platelet, and d-dimer levels and prothrombin time were obtained before, immediately after, and on the day after the procedure.
RESULTS: Five patients with venous malformations had positive d-dimer levels before the procedure. A subgroup analysis revealed a relationship between the type of agent used and the change in coagulation status. Specifically, a positive relationship was found between the use of dehydrated alcohol or sodium tetradecyl sulfate and a disruption in coagulation profiles as evidenced by a decrease in platelets and fibrinogen, an increase in prothrombin time, and a conversion from negative to positive d-dimers. In contrast, sclerotherapy or embolization with cyanoacrylic, polyvinyl alcohol foam particles, or platinum microcoils was not associated with coagulation disturbances.
CONCLUSION: The coagulation disturbances that occur in response to dehydrated alcohol or sodium tetradecyl sulfate sclerotherapy or embolization could compromise the patient's clotting ability. Patients who receive dehydrated alcohol or sodium tetradecyl sulfate during a preoperative sclerotherapy or embolization may experience coagulation disturbances that could increase the risk of bleeding, thrombosis, or hematoma. This patient population may benefit from the use of glue, foam, or coils as a substitute for dehydrated alcohol or sodium tetradecyl sulfate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11717083     DOI: 10.2214/ajr.177.6.1771359

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  14 in total

1.  Pharmacology of sclerotherapy.

Authors:  Giustino Albanese; Kimi L Kondo
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

2.  Characterization of thrombosis in patients with Proteus syndrome.

Authors:  Kim M Keppler-Noreuil; Jay N Lozier; Julie C Sapp; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2017-06-19       Impact factor: 2.802

3.  Imaging and percutaneous treatment of vascular anomalies.

Authors:  Sandeep Vaidya; Daniel Cooke; Matthew Kogut; Peter G Stratil; Mark A Bittles; Manrita Sidhu
Journal:  Semin Intervent Radiol       Date:  2008-09       Impact factor: 1.513

4.  Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects.

Authors:  Elisa Boscolo; Nisha Limaye; Lan Huang; Kyu-Tae Kang; Julie Soblet; Melanie Uebelhoer; Antonella Mendola; Marjut Natynki; Emmanuel Seront; Sophie Dupont; Jennifer Hammer; Catherine Legrand; Carlo Brugnara; Lauri Eklund; Miikka Vikkula; Joyce Bischoff; Laurence M Boon
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

5.  Superselective Intra-Arterial Ethanol Sclerotherapy of Feeding Artery and Nidal Aneurysms in Ruptured Cerebral Arteriovenous Malformations.

Authors:  F Settecase; S W Hetts; A D Nicholson; M R Amans; D L Cooke; C F Dowd; R T Higashida; V V Halbach
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-12       Impact factor: 3.825

6.  Association of localized intravascular coagulopathy with venous malformations.

Authors:  Anne Dompmartin; Aurélie Acher; Pascal Thibon; Sébastien Tourbach; Cédric Hermans; Véronique Deneys; Ben Pocock; Agnès Lequerrec; Daniel Labbé; Marie-Thérèse Barrellier; Romain Vanwijck; Miikka Vikkula; Laurence M Boon
Journal:  Arch Dermatol       Date:  2008-07

7.  Peri-procedural Anticoagulation in Patients with Head and Neck Versus Extremity Venous Malformations.

Authors:  Harish Dharmarajan; Jennifer L McCoy; Noel Jabbour; Andrew McCormick; Frederico Xavier; Debra Correa; Reema Padia
Journal:  Laryngoscope       Date:  2020-10-10       Impact factor: 3.325

8.  Glioblastoma multiforme in Klippel-Trenaunay-Weber syndrome: a case report.

Authors:  Tevfik Yilmaz; Ulas Cikla; Alice Kirst; Mustafa K Baskaya
Journal:  J Med Case Rep       Date:  2015-04-17

9.  Klippel-Trenaunay Syndrome Causing Life-Threatening GI Bleeding: A Case Report and Review of the Literature.

Authors:  Salih Samo; Muhammed Sherid; Husein Husein; Samian Sulaiman; Margaret Yungbluth; John A Vainder
Journal:  Case Rep Gastrointest Med       Date:  2013-06-03

10.  Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome.

Authors:  Kim M Keppler-Noreuil; Jay Lozier; Neal Oden; Anjali Taneja; Jasmine Burton-Akright; Julie C Sapp; Leslie G Biesecker
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-09-06       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.